Clinical trials: Cartilage Damage

Hip Osteoarthritis, Hip Impingement Syndrome

Losartan to Improve Hip Microfracture

• Terminated
• Age: 18 to 60 years
• Phase 1/2
• Pill or oral medicine
• Results posted

Phase I/IIA randomized, double-blind, placebo-controlled clinical trial to assess safety and efficacy of oral losartan for improving cartilage repair following microfracture to treat focal cartilage defects during hip arthroscopy.

Conditions

Hip Osteoarthritis, Hip Impingement Syndrome, Cartilage Damage, Fibrosis

Trial name

NCT04212650

Testing

Losartan

Where

United States

Volunteers

1 people

Sponsor

Steadman Philippon Research Institute